Idiopathic Pulmonary Fibrosis
Showing 26 - 50 of 350
Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement Trial in El Paso (Vixarelimab, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- Systemic Sclerosis With Lung Involvement
- Vixarelimab
- Placebo
-
El Paso, TexasEl Paso Pulmonary Association Elligo PPDS
Mar 14, 2023
Radiomics Algorithm for UIP Compared to Medical Doctors
Completed
- Idiopathic Pulmonary Fibrosis
- +2 more
- Radiomics model to classify between IPF with UIP pattern and ILDs without UIP pattern
-
Maastricht, Limburg, NetherlandsMaastricht University
Mar 14, 2023
Idiopathic Pulmonary Fibrosis Trial in Rome (Autologous FMT, Placebo FMT)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- Autologous FMT
- Placebo FMT
-
Rome, Roma, ItalyFondazione Policlinico Agostino Gemelli IRCCS
Feb 23, 2023
Idiopathic Pulmonary Fibrosis Trial (SHR-1906, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- SHR-1906
- Placebo
- (no location specified)
Feb 1, 2023
Idiopathic Pulmonary Fibrosis Trial (Ifetroban Sodium, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- Ifetroban Sodium
- Placebo
- (no location specified)
Jan 25, 2023
Idiopathic Pulmonary Fibrosis Trial (BI 1015550, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- BI 1015550
- Placebo
-
New Haven, Connecticut
- +134 more
Jan 23, 2023
All-Case Surveillance of Ofev in Patients With IPF in Japan
Recruiting
- Idiopathic Pulmonary Fibrosis
-
Multiple Locations, Japan(unnamed)
Jan 23, 2023
Idiopathic Pulmonary Fibrosis Trial in Worldwide (PRM-151 (Zinpentraxin Alfa), Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- PRM-151 (Zinpentraxin Alfa)
- Placebo
-
Birmingham, Alabama
- +407 more
Jan 19, 2023
Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Interstitial Pneumonitis Trial in Bethesda, Falls Church (Aerobic
Recruiting
- Interstitial Lung Disease
- +3 more
- Aerobic Exercise Training (AET)
- No AET (education only)
-
Bethesda, Maryland
- +1 more
Jan 18, 2023
Idiopathic Pulmonary Fibrosis Trial in United States (N-acetyl cysteine, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- N-acetyl cysteine
- Placebo
-
Tucson, Arizona
- +24 more
Jan 14, 2023
Idiopathic Pulmonary Fibrosis Trial (TTI-101, Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- TTI-101
- Placebo
- (no location specified)
Jan 3, 2023
Idiopathic Pulmonary Fibrosis Trial in Brooklyn (AZD5055, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- AZD5055
- Placebo
-
Brooklyn, MarylandResearch Site
Dec 22, 2022
Idiopathic Pulmonary Fibrosis Trial in United States (Placebo, Pirfenidone, Deupirfenidone)
Recruiting
- Idiopathic Pulmonary Fibrosis
- Placebo
- +2 more
-
Birmingham, Alabama
- +39 more
Dec 20, 2022
Idiopathic Pulmonary Fibrosis Trial in Beijing, Guangzhou, Shanghai (REGEND001 Autologous Therapy Product)
Recruiting
- Idiopathic Pulmonary Fibrosis
- REGEND001 Autologous Therapy Product
-
Beijing, Beijing, China
- +2 more
Dec 19, 2022
Idiopathic Pulmonary Fibrosis Trial in Worldwide (PRM-151 (Zinpentraxin Alfa))
Active, not recruiting
- Idiopathic Pulmonary Fibrosis
- PRM-151 (Zinpentraxin Alfa)
-
Birmingham, Alabama
- +241 more
Dec 16, 2022
Idiopathic Pulmonary Fibrosis Trial in Tours (intrapulmonary percussive ventilation, delivery of 99mTc-DTPA aerosol)
Recruiting
- Idiopathic Pulmonary Fibrosis
- intrapulmonary percussive ventilation
- delivery of 99mTc-DTPA aerosol
-
Tours, FrancePulmonology Department, University Hospital, Tours
Dec 7, 2022
Idiopathic Pulmonary Fibrosis Trial in Boston (PLN-74809, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- PLN-74809
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Nov 14, 2022
Idiopathic Pulmonary Fibrosis Trial in Palo Alto (PLN-74809, Knottin tracer)
Completed
- Idiopathic Pulmonary Fibrosis
- PLN-74809
- Knottin tracer
-
Palo Alto, CaliforniaStanford Medical Center
Nov 15, 2022
Idiopathic Pulmonary Fibrosis Trial in Worldwide (ND-L02-s0201, Other: Placebo)
Completed
- Idiopathic Pulmonary Fibrosis
- ND-L02-s0201
- Other: Placebo
-
Tucson, Arizona
- +32 more
Nov 15, 2022
Idiopathic Pulmonary Fibrosis, IPF Trial in Izmir (Inspiratory Muscle Training (IMT), Sham IMT)
Completed
- Idiopathic Pulmonary Fibrosis
- IPF
- Inspiratory Muscle Training (IMT)
- Sham IMT
-
Izmir, Balcova, TurkeyDokuz Eylul University
Nov 6, 2022
Interstitial Lung Disease, Sarcoidosis, Idiopathic Pulmonary Fibrosis Trial in Kansas City
Recruiting
- Interstitial Lung Disease
- +4 more
-
Kansas City, KansasThe University of Kansas Medical Center
Nov 5, 2022
Respiratory Muscle Strength in Idiopathic Pulmonary Fibrosis
Recruiting
- Idiopathic Pulmonary Fibrosis
- no intervention - cross-sectional observational only
-
Istanbul, Zeytinburnu, TurkeyYedikule Chest Disease Hospital
Nov 4, 2022
Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis Trial (Hyperoxia)
Not yet recruiting
- Interstitial Lung Disease
- +4 more
- Hyperoxia
- (no location specified)
Nov 1, 2022